Scale -

  • Revenue is 2365 Rs Cr; Annual Growth is 65 %; 5 Year CAGR is 22 %
  • Ebitda is 543 Rs Cr; Annual Growth is 32 %; Continuous Growth over 3 years; 5 Year CAGR is 15 %
  • PBT is 69.68 Rs Cr; Annual Growth is 29 %
  • PAT is 222 Rs Cr; Annual Growth is 39 %; 5 Year CAGR is 10 %
  • Quarterly Revenue is 655 Rs Cr; Continuous Growth over 3 Quarters
  • Quarterly Profit is 51.22 Rs Cr; Continuous Decline over 3 Quarters

Profitability -

  • PBDIT Margin is 22.95 %; in Top Quartile; Annual Decline is -20 %
  • Quarterly Ebitda Margin is 25 %; in Top Quartile
  • PAT Margin is 9.39 %; Annual Decline is -16 %; Continuous Decline over 3 years; 5 Year CAGR is -10 %
  • Quarterly Profit margin is 8 %; Continuous Decline over 3 Quarters

Return -

  • ROE is 5.1 %; Annual Growth is 56 %
  • Asset Turnover is 36 %; Annual Growth is 24 %; in Bottom Quartile
  • ROCE is 7.46 %; Continuous Decline over 3 years
  • ROA is 2.12 %; in Bottom Quartile; 5 Year CAGR is -20 %

Efficiency -

  • Operating cash flow is 334 Rs Cr; Annual Growth is 1210 %
  • Inventory Turnover Ratio is 1.47; in Bottom Quartile

Solvancy -

  • Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %; Continuous Decline over 3 years; in Bottom Quartile
  • Long term Debt is 511 Rs Cr; Annual Growth is 198 %; in Top Quartile
  • Total Debt is 1815 Rs Cr; Annual Growth is 38 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 23 %
  • Debt/Equity is 0.54; Continuous Growth over 3 years; in Top Quartile

Quality -

  • Operating cashflow/ebitda is 62 %; Annual Growth is 943 %
  • Operating cashflow/PAT is 150 %; Annual Growth is 899 %
  • Current Tax/PAT is 14 %; Annual Decline is -47 %; Continuous Decline over 3 years; in Bottom Quartile
  • Change in Inventories/Total Expenses is -6 %; in Bottom Quartile; Annual Growth is 79 %
  • Other Expenses/Total Expenses is 20 %; Annual Growth is 128 %; Continuous Growth over 3 years; 5 Year CAGR is 29 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers
Read More
  • Past/current